SEC Form 4 · accession 0000899243-18-015836
Cardiff Oncology, Inc. · CRDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
John P Brancaccio
Director
Period of report
Jun 8, 2018
Accepted (ET)
Jun 11, 2018 · 6:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001213037
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 8, 2018 | P | 10,000 | $0.80 | A | 53,167 | D |
Table II — derivative securities
No Table II lines on this filing.